Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
Q3 2025 vs. Q2 2025
How the institutions holding Olema Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 123 | 1 | 126 | +4 |
| Shares | 70.5M | 46.9K | 68.3M | −2.20M (−3.1%) |
| Value | $300.5M | $199.8K | $668.2M | +$367.9M (+122.5%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Silverarc Capital Management, LLC | 933,541 | $9.14M | 1.32% |
| Kingdon Capital Management, L.L.C. | 854,000 | $8.36M | 1.31% |
| Balyasny Asset Management LLC | 693,179 | $6.79M | 0.01% |
| Soleus Capital Management, L.P. | 619,874 | $6.07M | 0.32% |
| Point72 Asset Management, L.P. | 245,418 | $2.40M | 0.01% |
| Quantinno Capital Management LP | 40,330 | $394.8K | 0.00% |
| ADAR1 Capital Management, LLC | 36,200 | $354.4K | 0.04% |
| Campbell & CO Investment Adviser LLC | 29,048 | $284.4K | 0.02% |
| Mirae Asset Global ETFs Holdings Ltd. | 27,334 | $267.6K | 0.00% |
| Simplex Trading, LLC | 25,692 | $251.0K | 0.01% |
| Quarry LP | 18,751 | $183.6K | 0.04% |
| HRT Financial LP | 16,291 | $159.0K | 0.00% |
| Sender Co & Partners, Inc. | 10,793 | $105.7K | 0.04% |
| CI Private Wealth, LLC | 10,299 | $100.8K | 0.00% |
| Russell Investments Group, Ltd. | 5,399 | $52.9K | 0.00% |
| Principal Securities, Inc. | 466 | $4.56K | 0.00% |
| Point72 Europe (London) LLP | 404 | $3.96K | 0.00% |
| Optiver Holding B.V. | 236 | $2.31K | 0.00% |
| GAMMA Investing LLC | 231 | $2.26K | 0.00% |
| SRS Capital Advisors, Inc. | 5 | $49 | 0.00% |
Sold out (16)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| MPM Oncology Impact Management LP | 2,378,762 | $10.1M |
| Schroder Investment Management Group | 618,184 | $2.63M |
| Diadema Partners LP | 253,657 | $1.08M |
| Jacobs Levy Equity Management, Inc | 194,450 | $828.4K |
| XTX Topco Ltd | 80,414 | $342.6K |
| Thrivent Financial for Lutherans | 72,455 | $308.0K |
| ExodusPoint Capital Management, LP | 58,980 | $251.0K |
| Persistent Asset Partners Ltd | 58,333 | $248.5K |
| State of Wisconsin Investment Board | 54,177 | $230.8K |
| Prelude Capital Management, LLC | 22,133 | $94.3K |
| Sanctuary Advisors, LLC | 16,288 | $69.4K |
| Group One Trading, L.P. | 14,699 | $62.6K |
| Marshall Wace, LLP | 12,800 | $54.5K |
| US Bancorp | 30 | $128 |
| Advisor Group Holdings, Inc. | 5 | $21 |
| SWAN Capital LLC | 1 | $4 |
Not filed for Q3 2025 yet (1)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| EP Wealth Advisors, LLC | 46,905 | $199.8K |